Piperidinyl compound as a modulator of chemokine receptor activity
US8642622B2 · kind B2 · utility
3Cited by
14References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2011 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Mar 22, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes the compound of formula (I):or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and arthrosclerosis using the compound of the invention are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.